Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
21.94 USD | +5.68% | +0.09% | -28.34% |
Apr. 15 | Intellia Therapeutics, Inc. Appoints Michael P. Dube as Principal Accounting Officer | CI |
Mar. 25 | Intellia Therapeutics Ends Development Agreement With Regeneron Pharmaceuticals | MT |